Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01611246 · ClinicalTrials.gov registry record
Earset Healthy Volunteer Study
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 22
- Enrollment target
NCT01611246: Completed study, sponsored by Integra LifeSciences Corporation.
NCT01611246 is a clinical trial that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01611246 has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The study will recruit healthy volunteers to undergo the Iontophoresis procedure using the Acclarent Iontophoresis System with Earset (IPSES).
Interventions
- DEVICE Iontophoresis System With Earset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-05-01 |
| Est. Completion | 2012-08-01 |
What the finished NCT01611246 record still lists
NCT01611246 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Iontophoresis System With Earset is the first listed.
NCT01611246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01611246 about?
NCT01611246 is a clinical study titled "Earset Healthy Volunteer Study". The study will recruit healthy volunteers to undergo the Iontophoresis procedure using the Acclarent Iontophoresis System with Earset (IPSES).
What is the current status of trial NCT01611246?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2012-05-01. Estimated completion is 2012-08-01.
What interventions are being tested in trial NCT01611246?
The interventions under investigation include: Iontophoresis System With Earset (DEVICE).
Who is sponsoring clinical trial NCT01611246?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI